Alternative genotyping method of GSTT1 null/present polymorphism

Expert Review of Molecular Diagnostics

Volumn 6, Issue 6, 2006, Pages 873-877

  Naito, Mariko ^a   Goto, Yasuyuki ^a   Ishida, Yoshiko ^a   Nishio, Kazuko ^a   Kawai, Sayo ^a   Hamajima, Nobuyuki ^a  

^a Department of Preventive Medicine/Biostatistics and Medical Decision Making ^*  (Japan)

Author keywords

Detoxifying enzyme; Genotyping; GSTT1; PCR; Polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE T1;

ALLELE; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; DNA POLYMORPHISM; DNA SEQUENCE; GENE AMPLIFICATION; GENE FREQUENCY; GENE TARGETING; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; JAPAN; META ANALYSIS; POLYMERASE CHAIN REACTION; REVIEW; SYSTEMATIC REVIEW;

DISEASE; GENETIC SCREENING; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 33845400867     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.6.6.873     Document Type: Review

References (30)

1. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S- transferase family of enzymes. Mutat. Res. 482(1-2), 21-26 (2001).
2. Landi S. Mammalian class θ GST and differential susceptibility to carcinogens: a review. Mutat. Res. 463(3), 247-283 (2000).
3. Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Ann. Rev. Pharmacol. Toxicol. 45, 51-88 (2005).
4. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol. Biomarkers Prev. 6(9), 733-743 (1997).
5. Norppa H. Genetic susceptibility, biomarker responses, and cancer. Mutat. Res. 544(2-3), 339-348 (2003).
6. Parl FF. Glutathione S-transferase genotypes and cancer risk. Cancer Lett. 221(2), 123-129 (2005).
7. Sprenger R, Schlagenhaufer R, Kerb R et al. Characterization of the glutathione S-transferase GSTT1 deletion: discrimination of all genotypes by polymerase chain reaction indicates a trimodular genotype-phenotype correlation. Pharmocogenetics 10(6), 557-565 (1999). •• The enzyme activity of the GSTT1 heterozygote is lower than that of the present homozygote, which indicates the separation of the heterozygote is meaningful.
8. Infantte-Rivard C, Weinberg CR, Guiguet M. Xenobiotic-metablizing genes and small-for-gestational-age births interaction with maternal smoking. Epidemiology 17(1), 38-46 (2006).
9. Nishio K, Suzuki K, Ito Y et al. Possible interactions of the endothelial constitutive nitric oxide synthase genotype with alcohol drinking and walking time for high serum uric acid levels among Japanese. Metabolism 54(10), 1302-1308 (2005).
10. Kawai S, Nishio K, Nakamura S, Sekido Y, Niwa T, Hamajima N. Multiple PCR with confronting two-pair primers for CYP1A1 Ile462Val, GSTM1, GSTT1, and NQO1 C609T. Asian Pac. J. Cancer Prev. 6(3), 346-352 (2005).
11. Murata M, Watanabe M, Yamanaka M et al. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett. 165(2), 171-177 (2001).
12. Komiya Y, Tsukino H, Nakao H, Kuroda Y, Imai H, Katoh T. Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population. J. Cancer Res. Clin. Oncol. 131(4), 238-243 (2005).
13. Hamajima N, Takezaki T, Tajima K. Allele frequencies of 25 polymorphisms pertaining to cancer risk for Japanese, Koreans and Chinese. Asian Pac. J. Cancer Prev. 3(3), 197-206 (2002).
14. Garte S, Gaspari L, Alexandrie AK et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 10(12), 1239-1249 (2001).
15. Lai R, Crevier L, Thabane L. Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 14(7), 1784-1790 (2005).
16. Ye Z, Song H. Glutathione S-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systemic review and meta-analysis. Eur. J. Cancer 41(7), 980-989 (2005).
17. Ye Z, Song H, Higgins JP, Pharoah P, Danesh J. Five glutathione S-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies. PLoS. Med. 3(4), E91 (2006).
18. Saadat M. Genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci. 97(6), 505-509 (2006).
19. Chen K, Jiang Q-T, He H-Q. Relationship between metabolic enzyme polymorphism and colorectal cancer. World J. Gastroenterol. 11(3), 331-335 (2005).
20. Hashibe M, Brennan P, Strange RC et al. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol. Biomarkers Prev. 12(12), 1509-1517 (2003).
21. Yang CX, Matsuo K, Wang ZM, Tajima K. Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature. World J. Gastroenterol. 11(17), 2531-2538 (2005).
22. Vogl FD, Taioli E, Maugard C et al. Glutathione S-transferase M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol. Biomarkers Prev. 13(9) 1473-1479 (2004).
23. Ntais C, Polycarpou A, Ioannidis JP. Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol. Biomarkers Prev. 14(1), 176-181 (2005).
24. Wang X, Zuckerman B, Pearson C et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA 287(2), 195-202 (2002).
25. Audrain J, Boyd NR, Roth J, Main D, Caporaso NF, Lerman C. Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. Addict Behav. 22(6), 741-751 (1997).
26. McBride CM, Bepler G, Lipkus IM et al. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. Cancer Epidemiol Biomarkers Prev. 11(6), 521-528 (2002).
27. Hamajima N, Atsuta Y, Goto Y, Ito H. A pilot study on genotype announcement to induce smoking cessation by Japanese smokes. Asian Pac. J. Cancer Prev. 5(4) 409-413 (2004).
28. Ito H, Matsuo K, Wakai K et al. An intervention study of smoking cessation with feedback on genetic cancer susceptibility in Japan. Prev. Med. 42(2), 102-108, (2006).
29. Hamajima N, Suzuki K, Ito Y, Kondo T. Genotype announcement to Japanese smokers who attended a health checkup examination. J. Epidemiol. 16(1), 45-47 (2006). • Demonstrates that the GSTT1 genotype is applicable for smoking cessation program.
30. HT Biotech www.iit-biotech.de/iit-cgi/oligo-tm.pl